Plain-English translation of NCT06675383 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
After a stroke, doctors need to find out if an irregular heart rhythm called atrial fibrillation (AF) caused it, because catching this early can prevent another stroke. This trial compares two questions: Is it better to start monitoring your heart rhythm while you're still in the hospital right after your stroke, or after you go home? And does a 3-lead heart monitor (more detailed) find the problem better than a simpler 1-lead patch monitor? The study wants to figure out which approach catches more cases of irregular heartbeat.
Many people have atrial fibrillation without knowing it, and it can cause serious strokes. Doctors know they should screen stroke patients for this condition, but there's disagreement about when to start screening and which monitoring device works best. This trial exists to answer those questions so doctors can catch more cases early and prevent future strokes.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll be randomly assigned to one of two groups: one group will wear a heart monitor starting right away in the hospital after your stroke, while the other group will start monitoring after going home. Some participants will wear a 3-lead monitor (with more sensors) and others will wear a simpler 1-lead patch monitor. The monitors will track your heart rhythm continuously so doctors can detect any irregular heartbeats. You'll follow up with the research team to return your device and discuss the results.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
Norway
Sponsor
Vestre Viken Hospital Trust
Enrollment target
~410 participants
Started
November 2024
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Håkon Ihle-Hansen, MD PhD
Vestre Viken HF
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.